Latest papers

Acute immune-mediated thrombocytopenic purpura related to Toxoplasma gondii infection

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

Von Willebrand factor: another janus-faced hemostasis protein.

Successful treatment of acquired amegakaryocytic thrombocytopenic purpura refractory to corticosteroids and intravenous immunoglobulin with antithymocyte globulin and cyclosporin.

Haemophilus influenzae associated Guillain Barré Syndrome with thrombocytopenic purpura and hyperthermia.

[Recent advances of CD4(+)CD25(+) regulatory T cells in pathogenesis of idiopathic thrombocytopenic purpura - review].

A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children.

Percutaneous treatment of portal vein thrombosis in a child who has undergone splenectomy.

A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura.

Immune thrombocytopenic purpura.

[Novel medical treatment modalities in hematology]

Glomeruloid hemangioma.

Immune thrombocytopenic purpura as a complication of Bartonella henselae infection.

Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia associated with an occult large granular lymphocyte leukemia.

Delicate threads: autoimmune complications in a high-risk pregnancy.

ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions.

Toward better vaccine safety data and safer vaccination.

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.

Increasing the platelet count in chronic ITP.

Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?